SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-20-000249
Filing Date
2020-02-14
Accepted
2020-02-14 16:29:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 onconova_13gam4dec312019.htm SC 13G/A 36036
  Complete submission text file 0000905718-20-000249.txt   37719
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Subject) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87566 | Film No.: 20620677
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155
Business Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155 212-446-2466
TYNDALL CAPITAL PARTNERS L P (Filed by) CIK: 0001219314 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A